Human Genome (HGSI) and Glaxo (GSK) Announce Positive Pivitol BLISS-76 Phase 3 Results
Tweet Send to a Friend
Human Genome Sciences, Inc. (Nasdaq: HGSI) and GlaxoSmithKline PLC (NYSE: GSK) today announced topline secondary endpoints from BLISS-76, the second ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
